Page last updated: 2024-09-04

levofloxacin and Acute Yellow Atrophy

levofloxacin has been researched along with Acute Yellow Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ader, F; Collardeau-Frachon, S; Gillet, Y; Huguet, A; Ohlmann, C	1

Other Studies

1 other study(ies) available for levofloxacin and Acute Yellow Atrophy

Article	Year
Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin. The Pediatric infectious disease journal, 2019, Volume: 38, Issue:10 Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Latent Tuberculosis; Levofloxacin; Male; Massive Hepatic Necrosis; Pyrazinamide; Tuberculosis, Multidrug-Resistant	2019

Article

Year

Drug-Induced Fulminant Hepatitis in a Child Treated for Latent Multidrug-Resistant Tuberculosis With Dual Therapy Combining Pyrazinamide and Levofloxacin.

The Pediatric infectious disease journal, 2019, Volume: 38, Issue:10

Topics: Antitubercular Agents; Child; Drug Therapy, Combination; Humans; Latent Tuberculosis; Levofloxacin; Male; Massive Hepatic Necrosis; Pyrazinamide; Tuberculosis, Multidrug-Resistant

2019